Avernus to become exclusive supplier of SYNDROS® following approval by the Gulf Central Committee for Drug Registration
Press Release
Medra Brasil to become exclusive supplier of Benuvia’s SYNDROS® (dronabinol) in Brazil following Anvisa approval
The Department of Veterans Affairs will conduct a proof-of-concept trial of Cannabis derivatives in Neuropathic Pain (CDNP) including Benuvia’s SYNDROS® (dronabinol) oral solution, CII
The US House of Representatives on Monday evening passed the Biosecure Act with broad bipartisan support…
Mr. Novak brings three decades of executive leadership experience in the pharmaceutical, biotech, and contract development and manufacturing organization (CDMO) industries
Benuvia Operations, LLC, a leader in the development of innovative pharmaceutical cannabinoid and psychedelic products, is excited to announce a strategic partnership with Bright Green Corporation
Benuvia Operations, LLC and Chromocell Therapeutics Corp. Announce Strategic Partnership to Advance Healthcare Solutions
Co-marketing Agreement Designed to Promote Complementary CDMO and API Manufacturing Services to Drug Developers
Benuvia and PharmaCielo Announce Strategic Partnership to Manufacture cGMP Pharmaceutical-Grade CBD Isolate and Related Products
Wish
to learn more?
Wish to learn more?
Take the next step towards unlocking your product's potential.
Let's embark on a journey of innovation and success together.
